Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Lutai Pharmaceutical Co., Ltd., commonly known as Lutai Pharmaceutical, is a Chinese pharmaceutical company headquartered in Zibo, Shandong Province. The company specializes in the development, manufacturing, and commercialization of chemical drugs, including active pharmaceutical ingredients (APIs) and finished dosage forms. Its core therapeutic focuses include gastroenterology, anti-infectives, and cardiovascular health, with a product portfolio featuring high-demand generics such as omeprazole and cefuroxime. Lutai Pharmaceutical operates large-scale manufacturing facilities that are compliant with national Good Manufacturing Practice (GMP) standards. The company serves both the domestic healthcare market in China and various international export markets with its chemical medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lutai Pharmaceutical.